封面
市場調查報告書
商品編碼
2019467

全球正子斷層掃描(PET)掃描儀市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Positron Emission Tomography (PET) Scanners Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

正子斷層掃描(PET)掃描儀市場預計將從 2025 年的 19.8 億美元成長到 2034 年的 31.2 億美元,2026 年至 2034 年的複合年成長率為 5.18%。

由於慢性疾病(尤其是癌症和神經系統疾病)的盛行率不斷上升,全球正子斷層掃描(PET)掃描儀市場正經歷穩定成長。對早期精準診斷的需求日益成長,加之成像技術的進步,顯著推動了PET掃描儀的普及應用。 PET掃描儀因其在檢測代謝活動方面的高靈敏度,在腫瘤學和循環系統領域發揮著至關重要的作用。此外,全球人口老化也促進了市場擴張,因為老年人更容易患上需要先進診斷解決方案的複雜疾病。

關鍵成長要素包括PET/CT和PET/MRI等混合影像系統等技術創新,這些創新提高了診斷準確性。醫療成本上升、醫保報銷體系完善以及人們對早期疾病檢測重要性的認知不斷提高,也促進了市場擴張。此外,新興國家醫療基礎設施的擴建也擴大了先進影像系統的普及範圍。醫療服務提供者與設備製造商之間的策略合作進一步加速了全球新一代PET掃描儀的研發和部署。

預計未來PET掃描儀市場將迎來顯著成長,這主要得益於技術的不斷進步和精準醫療應用的不斷拓展。人工智慧(AI)和機器學習技術在影像分析中的應用將提升診斷效率並減少人為誤差。此外,放射性示蹤劑和分子影像技術的持續研究有望為疾病檢測和治療進展監測開闢新的途徑。新興市場在醫療現代化和基礎設施建設投資不斷增加的推動下,預計將在未來的成長中發揮關鍵作用。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球正子斷層掃描(PET)掃描器市場:依產品類型分類

  • 市場分析、洞察與預測
  • 全環PET掃描儀
  • 部分環形PET掃描儀

第5章 全球正子斷層掃描(PET)掃描器市場:依應用分類

  • 市場分析、洞察與預測
  • 循環系統
  • 神經病學
  • 腫瘤學
  • 整形外科
  • 泌尿系統
  • 胃腸病學
  • 其他

第6章 全球正子斷層掃描(PET)掃描器市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 診斷中心
  • 其他

第7章 全球正子斷層掃描(PET)掃描器市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Positron Corporation
    • CellSight Technologies
    • RefleXion Medical
    • Advanced Accelerator Applications
    • Blue Earth Diagnostics Limited
    • PETsys Electronics SA
    • Qubiotech Health Intelligence SL
    • Clarity Pharmaceuticals
    • Oncovision
    • CMR Naviscan
    • Neusoft Corporation
    • Siemens Healthineers AG
    • General Electric Company
    • Toshiba Corporation
簡介目錄
Product Code: VMR11215630

The Positron Emission Tomography (PET) Scanners Market size is expected to reach USD 3.12 Billion in 2034 from USD 1.98 Billion (2025) growing at a CAGR of 5.18% during 2026-2034.

The global Positron Emission Tomography (PET) scanners market is witnessing steady growth due to the rising prevalence of chronic diseases, particularly cancer and neurological disorders. Increasing demand for early and accurate diagnosis, coupled with advancements in imaging technologies, has significantly boosted adoption. PET scanners offer high sensitivity in detecting metabolic activity, making them crucial in oncology and cardiology applications. Additionally, the growing aging population worldwide further supports market expansion, as older individuals are more prone to complex health conditions requiring advanced diagnostic solutions.

Key growth drivers include technological innovations such as hybrid imaging systems like PET/CT and PET/MRI, which provide enhanced diagnostic accuracy. Increased healthcare expenditure, improved reimbursement policies, and rising awareness about early disease detection are also contributing factors. Moreover, expanding healthcare infrastructure in emerging economies is enabling broader access to advanced imaging systems. Strategic collaborations between healthcare providers and equipment manufacturers are further accelerating the development and deployment of next-generation PET scanners globally.

Looking ahead, the PET scanners market is expected to grow significantly, driven by continuous technological advancements and increasing applications in precision medicine. The integration of artificial intelligence and machine learning in imaging analysis will enhance diagnostic efficiency and reduce human error. Furthermore, ongoing research in radiotracers and molecular imaging is likely to open new avenues for disease detection and treatment monitoring. Emerging markets are anticipated to play a crucial role in future growth, supported by rising investments in healthcare modernization and infrastructure development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Full Ring PET Scanner's
  • Partial Ring PET Scanner's

By Applications

  • Cardiology
  • Neurology
  • Oncology
  • Orthopedics
  • Urology
  • Gastroenterology
  • Others

By End User

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others

COMPANIES PROFILED

  • Positron Corporation, CellSight Technologies, RefleXion Medical, Advanced Accelerator Applications, Blue Earth Diagnostics Limited, PETsys Electronics SA, Qubiotech Health Intelligence SL, Clarity Pharmaceuticals, Oncovision, CMR Naviscan, Neusoft Corporation, Siemens Healthineers AG, General Electric Company, Toshiba Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Full Ring PET Scanners Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Partial Ring PET Scanners Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET: BY APPLICATIONS 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Applications
  • 5.2. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.5. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.6. Urology Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.7. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET: BY END USER 2022-2034 (USD MN and K Units)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.4. Diagnostic Centres Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS MARKET: BY REGION 2022-2034 (USD MN and K Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.2.1 By Product Type
    • 7.2.2 By Applications
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.3.1 By Product Type
    • 7.3.2 By Applications
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.4.1 By Product Type
    • 7.4.2 By Applications
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.5.1 By Product Type
    • 7.5.2 By Applications
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.6.1 By Product Type
    • 7.6.2 By Applications
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Positron Corporation
    • 9.2.2 CellSight Technologies
    • 9.2.3 RefleXion Medical
    • 9.2.4 Advanced Accelerator Applications
    • 9.2.5 Blue Earth Diagnostics Limited
    • 9.2.6 PETsys Electronics SA
    • 9.2.7 Qubiotech Health Intelligence S.L
    • 9.2.8 Clarity Pharmaceuticals
    • 9.2.9 Oncovision
    • 9.2.10 CMR Naviscan
    • 9.2.11 Neusoft Corporation
    • 9.2.12 Siemens Healthineers AG
    • 9.2.13 General Electric Company
    • 9.2.14 Toshiba Corporation